PERISCOPE vs Octagos
The Octagos buyer is the device clinic of a cardiology group. The PERISCOPE buyer is a hospital surgical quality or infection prevention team. The two buyers do not overlap: one handles implantable device transmissions, the other post-operative infection risk.
Octagos names Epic, Oracle Health, athenahealth, medent and NextGen. The vendor says Atlas AI drafts reports from cardiac implantable device transmissions, a physician e-signature completes each one, and EHR go-live averages 21 days. Pro is software only, Premium adds clinical and patient engagement services, and Flex is on-demand, all without amounts.
PERISCOPE gives a surgical team a risk category and top contributing factors for postoperative infection, and the homepage links an ROI calculator in place of a price. The vendor says it holds ISO 13485 and ISO 27001. An Octagos-linked JACC Advances paper from 2025 reports Atlas AI at 99.1% sensitivity against 70.8% for technicians, in the vendor's reading. PERISCOPE rests on one retrospective multicentre study.
Decision support · Reviewed November 2, 2026
When to pick each one
PERISCOPE
- Risk category and top contributing factors per patient
- ISO 13485 and ISO 27001 stated
Octagos
- Epic, Oracle Health, athenahealth, medent and NextGen
- Physician e-signature on every report, per vendor
Score
Each row shows points earned of points available under the published rubric.
PERISCOPE
15of 100
Octagos
43of 100
| Dimension | PERISCOPE | Octagos | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 10 / 10 | -10 |
| EHR integrations (count) | 0 / 5.6 | 2.8 / 5.6 | -2.8 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 4.8 / 4.8 | -4.8 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 8.4 / 21 | 14.7 / 21 | -6.3 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
PERISCOPE
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Octagos
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
PERISCOPE
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
1 PubMed record names PERISCOPE.
Octagos
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
2 PubMed records name Octagos.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | PERISCOPE | Octagos |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, Oracle Health, athenahealth, medent, NextGen |
| Founded | n/a | n/a |
| HQ | NL | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.